TradingView
RocketTickers
14 авг 2018 г., 16:50
Motif Bio Announces FDA Acceptance of New Drug Application with
Длинная
NASDAQ:MTFB
Описание
⋅
14 авг 2018 г., 16:50
MTFB: Motif Bio plc
2018-08-14 02:00:00
Motif Bio Announces FDA Acceptance of New Drug Application with Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
Beyond Technical Analysis
Ещё